Commercialization: Page 104
-
PharmaVoice Team/PharmaVoice
Making the Web Patient Friendly
As patients and consumers continue to turn to the Internet for health-related information, pharmaceutical marketers are refining their search engine optimization (SEO) strategies to make sure information-hungry consumers are being correctly directed to the right sites. Getting, and Staying, on To...
By Elisabeth Pena Villarroel • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies U.S. Subsidiaries Form Daiichi Sankyo New U.S.-based company expected to fuel growth. Sankyo Pharma Inc., Daiichi Pharmaceutical Corp., and Daiichi Medical Research have integrated their U.S. businesses, creating a new pharmaceutical compan...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Celebrating Compliance
Celebrating compliance successes 5th Annual Patient Compliance, Adherence, and Persistency Conference AstraZeneca’s Commitment to Compliance Astrazeneca is focused on getting the best from every medicine it makes by exploring all the ways it can be used or improved. This commitment to innovation,...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Overemphasis on Salesforce May Shortchange Promotion
Larry Iaquinto of Interlink discusses why a well-balanced marketing program that includes advertising, public relations, and nonpersonal sales promotion is critical for getting the sales message to customers. Overemphasis on salesforce may shortchange promotion Larry Iaquinto, President and Chief...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
DIA Annual Meeting Showcase
DIA Annual Meeting Showcase A review of new products, tools, and services being launched by exhibitors at the 42nd Annual Meeting in Philadelphia, June 18-22. TrialCentralNet 4.0 gives our clients the flexibility to navigate the clinical-study process, communicate real-time study status to collea...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
A Rising Tide for Clinical Services
A Rising Tide for Clinical Services By Daniel Limbach June 2006 VIEW on Clinical Services Contract drug-development expenditures were $19 billion in 2005 and are expected to increase at an annual rate of 17%, eventually exceeding $42 billio...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Meet the R&D Leaders
By Denise Myshko Executives charged with R&D responsibilities within biotech and pharmaceutical organizations, both large and small, face myriad opportunities and challenges. Drug development is a costly and risky business. The pharmaceutical industry is challenged by many factors related to ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Linda DaSilva Kristina Duke Terri Fortenberry Sean Spears David Vaught Cathy Zhang Eisai Hires and Promotes Eisai, Teaneck, N.J., the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co. Ltd., has made several staff appointments. Linda DaSilva has been promoted to senior director, ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
On the Cover Meet the R&D leaders Executives charged with R&D responsibilities within biotech and pharmaceutical organizations — large and small — face myriad opportunities and challenges. FEATURES Making the Web patient friendly With a shift in marketing’s focus to direct-to-patient and ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
Politics and Healthcare Politics and healthcare are inextricably intertwined. What happens on the Hill inevitably impacts the medicine cabinet. But not all politics are good politics. We asked our readers to identify the politicians and lobbyists who understand the medical/pharmaceutical industry...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Throughout the year, PharmaVOICE strives to keep current with the trends and topics that impact our readers’ businesses and roles. We regularly issue e-mail questions soliciting responses for our monthly What’s Your Opinion question and e-surveys that complement various feature articles and Forum...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Office Visits — The Doctor Is In Docs Want More from Rep Calls Pfizer, Novartis, and GlaxoSmithKline have been identified as three companies whose sales reps are doing the best job of meeting the needs of physicians, but a TNS Healthcare study finds that there is room for improvement across the b...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Optimizing Sales Performance by Building Brand Commitment
Optimizing Sales Performance by Building Brand Commitment Jeffrey Zornitsky, Senior VP, Sales Performance Optimization Developing high-performing reps is an industry priority. Yet in spite of an annual investment of $24 billion, companies are missing the mark on creating programs that impro...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Positioning Sales Training as a Strategic Role in Pharmaceutical Organizations
Positioning Sales Training as a Strategic Role in Pharmaceutical Organizations George Schmidt, Senior Practice Executive, Sales Practice Those salesforces that best understand the changing marketplace and deliver valuable information to physicians will differentia...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Systematic Relationship Building is Key to Pharmaceutical Sales Success
Systematic Relationship Building is Key to Pharmaceutical Sales Success Pharmaceutical salespeople know their products’ features — and those of competitors — inside and out. Yet most reps have had little training in building relationships not only with the doctor, but with staff at...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Transferring the Learning
Content and design Transferring the Learning Bryan Horveath Executive Director, Ventiv Professional Development Group When looking up synonyms for the word “learn” two common verbs — study and find out — immediately pop up. Although both imply taking action, study tends to take on a more ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Training for success The sales training landscape may look significantly different in a year or two. While we can’t predict what the future will be, we do know that the industry is making improvements to every facet of the sales process. Good pharmaceutical sales reps know their products a...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Maximize Training Investment -- Regenerative Learning Elements: Share, Stratify, and Adapt
PLEXUS Learning Designs Maximize Training Investment — Regenerative Learning Elements: Share, Stratify, and Adapt Ruth A Vukelich, President and CEO Ours is a very dynamic industry, driven by accelerated timelines and budget constraints. In addition, training requirements demand top-quality,...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Rebuilding the Trust -- Sales Managers Lead the Charge
Rebuilding the Trust — Sales Managers Lead the Charge Tom Roth President Celeste Mosby VP of Industry Marketing for Life Sciences Building Trust Over the last few years, industry changes have made it essential for representatives to do a few things very well. For example representative...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Onboarding Continuum Using E-Learning to Extend Reach and Results
The Onboarding Continuum Using E-Learning to Extend Reach and Results Jim Delaney VP, Learning Strategy There is growing concern over high salesforce turnover, especially within the first year of employment. In looking for a root cause, the finger often points in the direction of the new hi...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Table of Contents VIEW on Sales Training May 2006 Letter from the Editor The Forum Sales Training: More important than ever. Knowledge, relationship building, and technology are some of the key factors that can make a good rep a great rep. Company Listing by Topic of Interest Content and Design i...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Training for Increased Effectiveness
Training for Increased Effectiveness Jim Dutton, President In addition to enhancing relationships with physicians, in-depth knowledge around disease-state areas, broadened with business ethics, skilled management, and industry knowledge can improve retention and allow...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
Ventiv Health Changes Name to Reflect Broader Capabilities Rebranding initiative integrates inChord nomenclature to more clearly communicate services. Ventiv Health Inc. has changed its corporate brand name to inVentiv Health as part of a rebranding initiative that began when Ventiv acquired inCh...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Combination Products: Drugs and Devices
The possibilities are endless. Emerging drug-delivery technologies and smarter drug-development strategies are providing a one-two punch for researchers and marketers who envision scientific advancements that could span multiple therapeutic categories. By Denise Myshko In the broadest sense, phar...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Role of District Sales Managers in Maximizing Incentive Program Spend
Spend Stan Striker, VP, Managing Consultant, of Maritz Incentives discusses why salesforce member retention is a pressing concern for companies; the cost of turnover may be as much as one and a half times an employee’s first year salary. Being on the front line of working with the salesforce, dis...
By PharmaVoice Team • Jan. 2, 2008
Previous
